Affiliation:
1. Shiraz University of Medical Sciences,Pharmaceutical Sciences Research Center,Shiraz,Iran,
2. Henan University of Science and Technology,Henan Key Laboratory of Environmental and Animal Product Safety,Henan,China,
Abstract
The cytoprotective features of taurine (TAU), including anti-programmed cell death, membrane stabilization, antioxidant, anti-inflammation, osmoregulation, and intracellular calcium homeostasis regulation, have been well addressed in the literature. TAU has also been considered a potent agent for diminishing various xenobiotics caused by physiological and pathophysiological alterations through its antioxidant action in reproductive and non-reproductive organs. Hence, exogenous TAU administration is the topic of many in-depth investigations. Several studies revealed that the antioxidative effect, anti-cellular death, and anti-inflammatory effects of TAU are involved in inhibiting xenobiotics-induced reproductive toxicity. Hence, the exact targets of TAU during the intracellular routes related to mitochondrial functionality (such as mitochondria-mediated oxidative stress and cell death) triggered by xenobiotics are discussed in this chapter. The data collected in this chapter suggest that TAU could be highly protective against various kinds of xenobiotics-induced gonadotoxicity, spermatotoxicity, and steroidogenotoxicity (hormonal steroids’ genotoxicity) via its antioxidative, anti-inflammatory, and anti-cell death features. Furthermore, this amino acid also acts as an anti-apoptotic and anti-autophagic molecule by modifying the regulation of some related genes and proteins and inflammatory and mitochondrial-dependent signaling molecules.<br>
Publisher
BENTHAM SCIENCE PUBLISHERS
Reference167 articles.
1. Van der Horst C.; Hypotaurine in the reproductive tract Natural Sulfur Compounds 1980,225-234
2. Fellman J.H.; Roth E.S.; The biological oxidation of hypotaurine to taurine: hypotaurine as an antioxidant. Prog Clin Biol Res 1985,179,71-82
3. Aruoma O.I.; Halliwell B.; Hoey B.M.; Butler J.; The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 1988,256(1),251-255
4. Holmes R.P.; Goodman H.O.; Shihabi Z.K.; Jarow J.P.; The taurine and hypotaurine content of human semen. J Androl 1992,13(3),289-292
5. Jacobsen J.G.; Smith L.H.; Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968,48(2),424-511